Importance of antimicrobial stewardship to the English National Health Service by Dixon J, Duncan CJA

Get full text

Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia by Hanrath, AT, Hatton, CF, Gothe, F, Browne, C, Vowles, J, Leary, P, Cockell, SJ, Cowley, SA, James, WS, Hambleton, S, Duncan, CJA

Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency by Gothe, F, Spegarova, JS, Hatton, CF, Griffin, H, Sargent, T, Cowley, SA, James, W, Roppelt, A, Shcherbina, A, Hauck, F, Reyburn, HT, Duncan, CJA, Hambleton, S

Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience by Shields, AM, Tadros, S, Al-Hakim, A, Nell, JM, Lin, MMN, Chan, M, Goddard, S, Dempster, J, Dziadzio, M, Patel, SY, Elkalifa, S, Huissoon, A, Duncan, CJA, Herwadkar, A, Khan, S, Bethune, C, Elcombe, S, Thaventhiran, J, Klenerman, P, Lowe, DM, Savic, S, Burns, SO, Richter, AG

Poor antibody responses to SARS-CoV-2 infection or vaccination are associated with high re-infection rates in haemodialysis and renal transplant patients by Shankar, S, Beckett, J, Tipton, T, Ogbe, A, Kasanyinga, M, Dold, C, Lumley, S, Dengu, F, Rompianesi, G, Elgilani, F, Longet, S, Deeks, A, Payne, RP, Duncan, CJA, Richter, AG, Silva, TI, Turtle, L, Bull, K, Barnardo, M, Dunachie, S, Hester, J, Friend, P, Issa, F, Barnes, E, Carroll, MW, Klenerman, P

SARS-CoV-2-specific T cell responses are not associated with protection against reinfection in hemodialysis patients by Shankar, S, Beckett, J, Tipton, T, Ogbe, A, Kasanyinga, M, Dold, C, Lumley, S, Dengu, F, Rompianesi, G, Elgilani, F, Longet, S, Deeks, A, Payne, RP, Duncan, CJA, Richter, A, de Silva, TI, Turtle, L, Bull, K, Barnardo, M, Friend, PJ, Dunachie, SJ, Hester, J, Issa, F, Barnes, E, Carroll, MW, Klenerman, P

Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history by Hornsby, H, Nicols, AR, Longet, S, Liu, C, Tomic, A, Angyal, A, Kronsteiner, B, Tyerman, JK, Tipton, T, Zhang, P, Gallis, M, Supasa, P, Selvaraj, M, Abraham, P, Neale, I, Ali, M, Barratt, NA, Nell, JM, Gustafsson, L, Strickland, S, Grouneva, I, Rostron, T, Moore, SC, Hering, LM, Dobson, SL, Bibi, S, Mongkolsapaya, J, Lambe, T, Wootton, D, Hall, V, Hopkins, S, Dong, T, Barnes, E, Screaton, G, Richter, A, Turtle, L, Rowland-Jones, SL, Carroll, M, Duncan, CJA, Klenerman, P, Dunachie, SJ, Payne, RP, de Silva, TI

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a sing... by Stuart, ASV, Shaw, RH, Liu, X, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Darton, T, Dinesh, T, Duncan, CJA, England, A, Faust, SN, Ferreira, DM, Finn, A, Goodman, AL, Green, CA, Hallis, B, Heath, PT, Hill, H, Horsington, BM, Lambe, T, Lazarus, R, Libri, V, Lillie, PJ, Mujadidi, YF, Payne, R, Plested, EL, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, PJ, Vichos, I, White, R, Nguyen-Van-Tam, JS, Snape, MD

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK by Voysey, M, Clemens, SAC, Madhi, SA, Weckx, LY, Folegatti, PM, Aley, PK, Angus, B, Baillie, VL, Barnabas, SL, Bhorat, QE, Bibi, S, Briner, C, Cicconi, P, Collins, AM, Colin-Jones, R, Cutland, CL, Darton, TC, Dheda, K, Duncan, CJA, Emary, KRW, Ewer, KJ, Fairlie, L, Faust, SN, Feng, S, Ferreira, DM, Finn, A, Goodman, AL, Green, CM, Green, CA, Heath, PT, Hill, C, Hill, H, Hirsch, I, Hodgson, SHC, Izu, A, Jackson, S, Jenkin, D, Joe, CCD, Kerridge, S, Koen, A, Kwatra, G, Lazarus, R, Lawrie, AM, Lelliott, A, Libri, V, Lillie, PJ, Mallory, R, Mendes, AVA, Milan, EP, Minassian, AM, Lambe, T, Pollard, AJ

AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific Th1 response with a diverse TCR repertoire. by Swanson, PA, Padilla, M, Hoyland, W, McGlinchey, K, Fields, PA, Bibi, S, Faust, SN, McDermott, AB, Snape, MD, Voysey, M, Lambe, T, Pollard, AJ, Durham, NM, Kelly, EJ, Adlou, S, Aley, PK, Angus, B, Anslow, R, Baker, P, Bansal, H, Beveridge, A, Bridges-Webb, A, Ching, S, Cicconi, P, Clutterbuck, EA, Collins, AM, Darton, TC, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Ewer, KJ, Felle, S, Ferreira, DM, Folegatti, PM, Fuskova, M, Gaudinski, M, Gilbert, SC, Goodman, AL, Gordon, I, Green, CA, Harbolick, E, Hayes, S, Hill, AVS, Hill, H, Jenkin, D, Jepson, BM, Kasanyinga, M, Libri, V, Lillie, PJ, McGregor, AC

Clinical features and management of human monkeypox: a retrospective observational study in the UK by Adler, H, Gould, S, Hine, P, Snell, LB, Wong, W, Houlihan, CF, Osborne, JC, Rampling, T, Beadsworth, MBJ, Duncan, CJA, Dunning, J, Fletcher, TE, Hunter, ER, Jacobs, M, Khoo, SH, Newsholme, W, Porter, D, Porter, RJ, Ratcliffe, L, Schmid, ML, Semple, MG, Tunbridge, AJ, Wingfield, T, Price, NM, Abouyannis, M, Al-Balushi, A, Aston, S, Ball, R, Beeching, NJ, Blanchard, TJ, Carlin, F, Davies, G, Gillespie, A, Hicks, SR, Hoyle, M-C, Ilozue, C, Mair, L, Marshall, S, Neary, A, Nsutebu, E, Parker, S, Ryan, H, Turtle, L, Smith, C, van Aartsen, J, Walker, NF, Woolley, S, Chawla, A, Hart, I, Smielewska, A

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study by Angyal, A, Longet, S, Moore, SC, Payne, RP, Harding, A, Tipton, T, Rongkard, P, Ali, M, Hering, LM, Meardon, N, Austin, J, Brown, R, Skelly, D, Gillson, N, Dobson, SL, Cross, A, Sandhar, G, Kilby, JA, Tyerman, JK, Nicols, AR, Spegarova, JS, Mehta, H, Hornsby, H, Whitham, R, Conlon, CP, Jeffery, K, Goulder, P, Frater, J, Dold, C, Pace, M, Ogbe, A, Brown, H, Ansari, MA, Adland, E, Brown, A, Chand, M, Shields, A, Matthews, PC, Hopkins, S, Hall, V, James, W, Rowland-Jones, SL, Klenerman, P, Dunachie, S, Richter, A, Duncan, CJA, Barnes, E, Carroll, M, Turtle, L, de Silva, TI

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine by Payne, RP, Longet, S, Austin, JA, Skelly, DT, Dejnirattisai, W, Adele, S, Meardon, N, Faustini, S, Al-Taei, S, Moore, SC, Tipton, T, Hering, LM, Angyal, A, Brown, R, Nicols, AR, Gillson, N, Dobson, SL, Amini, A, Supasa, P, Cross, A, Bridges-Webb, A, Reyes, LS, Linder, A, Sandhar, G, Kilby, JA, Tyerman, JK, Altmann, T, Hornsby, H, Whitham, R, Phillips, E, Malone, T, Hargreaves, A, Shields, A, Saei, A, Foulkes, S, Stafford, L, Johnson, S, Wootton, DG, Conlon, CP, Jeffery, K, Matthews, PC, Frater, J, Deeks, AS, Pollard, AJ, Brown, A, Rowland-Jones, SL, Mongkolsapaya, J, Barnes, E, Hopkins, S, Hall, V, Dold, C, Duncan, CJA, Richter, A, Carroll, M, Screaton, G, de Silva, TI, Turtle, L, Klenerman, P, Dunachie, S